Pharma BD Deal Intelligence
Abbott Laboratories / Vysis Inc.
2001 · Acquisition/Merger · $355M · Complete
Announcement Sentiment
93
Strongly positive
$30.50/share cash (33% premium). Genomic disease management/FISH probes — became core of Abbott Molecular oncology dx franchise.
Key facts
- Announced Oct 24, 2001
- Deal value $355M
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals